Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2021-08-12
Product name
LAMIVUDINE TABLETS 150 & 300 MG
Product Synonyms
3TC * 3TC-OTC * 3TC TABLETS-ATM * EPIVIR-ATM * EPIVIR 3TC * LAMIVUDINE 150 & 300 MG
1.2.2. Uses advised against
No other uses are advised
Manufacturer Name
ViiV
Icons in SDS
Company Information
company name
ViiV
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361, H373
Hazard statements
Code
Statements
H361
Suspected of damaging fertility or the unborn child
Section 2
Physical hazards
Not classified.
Health hazards
Reproductive toxicity Category 2 Specific target organ toxicity following Category 2 repeated exposure
Environmental hazards
Not classified.
Signal word
Warning
Hazard statements
H361 Suspected of damaging fertility or the unborn child. H373 May cause damage to organs through prolonged or repeated exposure.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P280 Wear protective gloves/protective clothing/eye protection/face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
Assume that this material is capable of sustaining combustion. Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
48.5 % of the mixture consists of component(s) of unknown acute oral toxicity. 100 % of the mixture consists of component(s) of unknown acute dermal toxicity. 51.5 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 51.5 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment. National/local information Not available
